Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$121.06
-$1.69 (-1.4%)
Closing price December 3, 2020
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Friday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Callaway Golf, Facebook, Illumina, iRobot, Six Flags, Starbucks, Twitter and Yandex.
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft, Pfizer and Wynn Resorts.
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive strategies is biotech and pharmaceuticals.
Wednesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Amazon.com, Diageo, eBay, Etsy, Home Depot, MGIC Investment, Netflix, Sirius XM and Vir Biotechnology.
Announcements that Alexion Pharmaceuticals made at its virtual Investor Day about expanding its pipeline and its guidance led to a handy gain in its shares on Tuesday.
Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and Shopify.
The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.